KAYLA CHESSER-MURRAY: Open Payments
NPI 1902447394 · ST AUGUSTINE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,145 in 48 payments from 12 companies in 2025. Trend: 2023 $296 · 2024 $486 · 2025 $1,145
Food & beverage: $1,145
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $386 |
| Madrigal Pharmaceuticals | 5 | $221 |
| GENZYME CORPORATION | 4 | $92 |
| Janssen Biotech, Inc. | 4 | $90 |
| Aimmune Therapeutics, Inc. | 3 | $75 |
| Regeneron Healthcare Solutions, Inc. | 4 | $75 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $66 |
| Exact Sciences Corporation | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Gilead Sciences, Inc. | 1 | $28 |
Products named: REZDIFFRA, DUPIXENT, SKYRIZI, LINZESS, TREMFYA, ZENPEP, XIFAXAN, RINVOQ.
Industry payments across FL — which companies pay providers there.
